These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25223735)

  • 21. Signaling Inhibitors Accelerate the Conversion of mouse iPS Cells into Cancer Stem Cells in the Tumor Microenvironment.
    Du J; Xu Y; Sasada S; Oo AKK; Hassan G; Mahmud H; Khayrani AC; Alam MJ; Kumon K; Uesaki R; Afify SM; Mansour HM; Nair N; Zahra MH; Seno A; Okada N; Chen L; Yan T; Seno M
    Sci Rep; 2020 Jun; 10(1):9955. PubMed ID: 32572057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteopontin Promotes Colorectal Cancer Cell Invasion and the Stem Cell-Like Properties through the PI3K-AKT-GSK/3β-β/Catenin Pathway.
    Cheng Y; Wen G; Sun Y; Shen Y; Zeng Y; Du M; Zhu G; Wang G; Meng X
    Med Sci Monit; 2019 Apr; 25():3014-3025. PubMed ID: 31017126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. THBS4 silencing regulates the cancer stem cell-like properties in prostate cancer via blocking the PI3K/Akt pathway.
    Hou Y; Li H; Huo W
    Prostate; 2020 Jul; 80(10):753-763. PubMed ID: 32421868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation.
    Kumar SM; Liu S; Lu H; Zhang H; Zhang PJ; Gimotty PA; Guerra M; Guo W; Xu X
    Oncogene; 2012 Nov; 31(47):4898-911. PubMed ID: 22286766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CXCR6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells.
    Taghizadeh R; Noh M; Huh YH; Ciusani E; Sigalotti L; Maio M; Arosio B; Nicotra MR; Natali P; Sherley JL; La Porta CA
    PLoS One; 2010 Dec; 5(12):e15183. PubMed ID: 21203549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer cells acquire a drug resistant, highly tumorigenic, cancer stem-like phenotype through modulation of the PI3K/Akt/β-catenin/CBP pathway.
    He K; Xu T; Xu Y; Ring A; Kahn M; Goldkorn A
    Int J Cancer; 2014 Jan; 134(1):43-54. PubMed ID: 23784558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PI3K/Akt inhibitor partly decreases TNF-α-induced activation of fibroblast-like synoviocytes in osteoarthritis.
    Liu S; Cao C; Zhang Y; Liu G; Ren W; Ye Y; Sun T
    J Orthop Surg Res; 2019 Dec; 14(1):425. PubMed ID: 31829201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sec23a inhibits the self-renewal of melanoma cancer stem cells via inactivation of ER-phagy.
    Sun Z; Liu D; Zeng B; Zhao Q; Li X; Chen H; Wang J; Rosie Xing H
    Cell Commun Signal; 2022 Mar; 20(1):22. PubMed ID: 35236368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma.
    Petrachi T; Romagnani A; Albini A; Longo C; Argenziano G; Grisendi G; Dominici M; Ciarrocchi A; Dallaglio K
    Oncotarget; 2017 Jan; 8(4):6914-6928. PubMed ID: 28036292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of lncRNA H19 inhibits the migration and invasion of melanoma cells by inactivating the NF‑κB and PI3K/Akt signaling pathways.
    Liao Z; Zhao J; Yang Y
    Mol Med Rep; 2018 May; 17(5):7313-7318. PubMed ID: 29568965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The PI3K/AKT/c-MYC Axis Promotes the Acquisition of Cancer Stem-Like Features in Esophageal Squamous Cell Carcinoma.
    Zhang HF; Wu C; Alshareef A; Gupta N; Zhao Q; Xu XE; Jiao JW; Li EM; Xu LY; Lai R
    Stem Cells; 2016 Aug; 34(8):2040-51. PubMed ID: 27144349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in cancer stem cells.
    Martelli AM; Evangelisti C; Follo MY; Ramazzotti G; Fini M; Giardino R; Manzoli L; McCubrey JA; Cocco L
    Curr Med Chem; 2011; 18(18):2715-26. PubMed ID: 21649579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Honokiol inhibits melanoma stem cells by targeting notch signaling.
    Kaushik G; Venugopal A; Ramamoorthy P; Standing D; Subramaniam D; Umar S; Jensen RA; Anant S; Mammen JM
    Mol Carcinog; 2015 Dec; 54(12):1710-21. PubMed ID: 25491779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. STAT3-induced ZBED3-AS1 promotes the malignant phenotypes of melanoma cells by activating PI3K/AKT signaling pathway.
    Wang Y; Lou N; Zuo M; Zhu F; He Y; Cheng Z; Wang X
    RNA Biol; 2021 Oct; 18(sup1):355-368. PubMed ID: 34241580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Berberine protects endothelial progenitor cell from damage of TNF-α via the PI3K/AKT/eNOS signaling pathway.
    Xiao M; Men LN; Xu MG; Wang GB; Lv HT; Liu C
    Eur J Pharmacol; 2014 Nov; 743():11-6. PubMed ID: 25257463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The inflammatory cytokine TNF-α promotes the premature senescence of rat nucleus pulposus cells via the PI3K/Akt signaling pathway.
    Li P; Gan Y; Xu Y; Song L; Wang L; Ouyang B; Zhang C; Zhou Q
    Sci Rep; 2017 Feb; 7():42938. PubMed ID: 28211497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of lncRNA-MALAT1 and miR-124 regulates HBx-induced cancer stem cell properties in HepG2 through PI3K/Akt signaling.
    He B; Peng F; Li W; Jiang Y
    J Cell Biochem; 2019 Mar; 120(3):2908-2918. PubMed ID: 30500989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythropoietin activates the phosphoinositide 3-kinase/Akt pathway in human melanoma cells.
    Kumar SM; Yu H; Fong D; Acs G; Xu X
    Melanoma Res; 2006 Aug; 16(4):275-83. PubMed ID: 16845323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PI3K mediates protection against TRAIL-induced apoptosis in primary human melanocytes.
    Larribere L; Khaled M; Tartare-Deckert S; Busca R; Luciano F; Bille K; Valony G; Eychene A; Auberger P; Ortonne JP; Ballotti R; Bertolotto C
    Cell Death Differ; 2004 Oct; 11(10):1084-91. PubMed ID: 15243584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.